Genetic Sequencing tests in Dubai & UAE

Compare available Genetic Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

256

Listed price range

2,600.00–5,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Sequencing test prices

Showing 136–150 of 256 matching tests.

Genetic Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5160 KRT14 Gene Epidermolysis Bullosa Simplex, Koebner Type Genetic Test This genetic test evaluates the KRT14 gene for pathogenic variants associated with Epidermolysis Bullosa Simplex, Koebner type.	Whole Blood (3–5 mL in EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KRT14 gene coding region", "KRT14 gene splice sites", "Single-nucleotide variants (SNVs)", "Insertions and deletions (indels)", "Copy-number variants (CNVs)"] Parameters [] Preparation ["Informed consent required", "Pre-test genetic counselling recommended"] Indications ["Suspected Epidermolysis Bullosa Simplex, Koebner type", "Family history of EBS", "Need for precise molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q81.0 Clinical summary This genetic test evaluates the KRT14 gene for pathogenic variants associated with Epidermolysis Bullosa Simplex, Koebner type.
TEST-4607 L1CAM Gene Hydrocephalus with Aqueductal Stenosis & Congenital Intestinal Pseudo-Obstruction Test This genetic test evaluates the L1CAM gene for pathogenic variants associated with congenital hydrocephalus with aqueductal stenosis and intestinal pseudo-obstruction.	Whole Blood (Peripheral Venous Blood)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the L1CAM gene"] Parameters [] Preparation ["No fasting required", "Hydrate well", "Wear loose clothing", "Legal guardian present for minors"] Indications ["Suspected X-linked hydrocephalus with aqueductal stenosis", "Suspected congenital intestinal pseudo-obstruction", "Family history of L1CAM-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21790-1 ICD-10: Q03.0, Q43.8 Clinical summary This genetic test evaluates the L1CAM gene for pathogenic variants associated with congenital hydrocephalus with aqueductal stenosis and intestinal pseudo-obstruction.
TEST-5149 LAMA3 Gene (Epidermolysis Bullosa, Junctional, Herlitz Type) Genetic Test This test evaluates the LAMA3 gene for pathogenic variants associated with Herlitz junctional epidermolysis bullosa (JEB-H).	Whole Blood, Extracted DNA, or FTA Card Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LAMA3 gene sequence", "Pathogenic variants (point mutations, insertions/deletions, copy number variants)"] Parameters [] Preparation ["Clinical history required", "Genetic counseling session mandatory", "Pedigree chart of affected family members required"] Indications ["Suspected Herlitz junctional epidermolysis bullosa (JEB-H)", "Family history of JEB-H", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81305-1 ICD-10: Q81.1 Clinical summary This test evaluates the LAMA3 gene for pathogenic variants associated with Herlitz junctional epidermolysis bullosa (JEB-H).
TEST-3808 LAMA5 Gene Sequencing (Focal Segmental Glomerulosclerosis, LAMA5‑Related) Genetic Test This test detects pathogenic variants in the LAMA5 gene associated with hereditary focal segmental glomerulosclerosis (FSGS). It provides a molecular diagnosis for this specific ty...	Peripheral Whole Blood or FTA Card Sample	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LAMA5 gene", "Laminin alpha-5 protein function"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Suspected hereditary FSGS", "Family history of FSGS", "Diagnosis of nephrotic syndrome of unknown cause"] Measurement technique Confirm with laboratory Codes LOINC: 81263-5 ICD-10: N04.1 Clinical summary This test detects pathogenic variants in the LAMA5 gene associated with hereditary focal segmental glomerulosclerosis (FSGS). It provides a molecular diagnosis for this specific type of kidney disease.
TEST-2641 LAMB1 Gene Lissencephaly Type 5 Genetic Test This test identifies pathogenic variants within the LAMB1 gene, confirming the genetic basis for Lissencephaly Type 5.	Peripheral whole blood (venous or finger-prick)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LAMB1 gene coding region variants", "Pathogenic mutations associated with LIS5"] Parameters [] Preparation [] Indications ["Clinical suspicion of Lissencephaly Type 5", "Confirmation of diagnosis following brain imaging", "Genetic counseling for recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q04.3 Clinical summary This test identifies pathogenic variants within the LAMB1 gene, confirming the genetic basis for Lissencephaly Type 5.
TEST-2438 LAMC1 Gene Pelvic Organ Prolapse, LAMC1‑Related Genetic Test This diagnostic test evaluates the LAMC1 gene for pathogenic variants associated with pelvic organ prolapse and related syndromes.	Blood (Whole Blood or FTA Card) or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LAMC1 gene variants", "Single nucleotide variants (SNVs)", "Insertions and deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation [] Indications ["Individuals with early-onset prolapse", "Family history of connective tissue disorders", "Clinical signs requiring molecular confirmation for targeted management"] Measurement technique Confirm with laboratory Codes LOINC: 86299-5 ICD-10: N81.9, Q87.89, Z13.79 Clinical summary This diagnostic test evaluates the LAMC1 gene for pathogenic variants associated with pelvic organ prolapse and related syndromes.
TEST-5074 LBR Gene Greenberg Skeletal Dysplasia Next-Generation Sequencing (Genetic Test This genetic test evaluates the LBR gene for pathogenic variants associated with Greenberg skeletal dysplasia.	Whole blood (EDTA), FTA card, or extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LBR gene sequence", "Copy Number Variants (CNVs) in LBR gene"] Parameters [] Preparation ["Bring all previous medical reports", "Bring ultrasound images", "List of affected relatives"] Indications ["Clinical suspicion of Greenberg skeletal dysplasia", "Family history of Greenberg skeletal dysplasia", "Need for definitive genetic diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 92864-1 ICD-10: Q77.1 Clinical summary This genetic test evaluates the LBR gene for pathogenic variants associated with Greenberg skeletal dysplasia.
TEST-2459 LBR Gene Pelger-Huët Anomaly Next-Generation Sequencing (Genetic Test This test evaluates the LBR gene for variants associated with Pelger-Huët anomaly, a condition affecting neutrophil morphology.	Whole blood (EDTA), extracted DNA, or FTA card (dried blood spot)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LBR gene variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation [] Indications ["Evaluating children with unexplained dysmorphism", "Recurrent infections", "Suspected hereditary neutropenia", "Pelger-Huët anomaly screening", "Confirming suspected Pelger-Huët anomaly in newborns", "Establishing molecular diagnosis for family planning", "Cascade testing", "Genotype-phenotype correlation"] Measurement technique Confirm with laboratory Codes LOINC: 34179-6 ICD-10: D72.0 Clinical summary This test evaluates the LBR gene for variants associated with Pelger-Huët anomaly, a condition affecting neutrophil morphology.
TEST-3770 LHB Gene Hypogonadotropic Hypogonadism Genetic Test This test identifies pathogenic variants in the LHB gene associated with hypogonadotropic hypogonadism.	Whole Blood (EDTA Tube), Extracted DNA (Minimum 1 µg), One Drop Blood on FTA Card, DNA FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LHB gene", "Copy Number Variants (CNV)"] Parameters [] Preparation ["Avoid biotin (Vitamin B7) supplementation for at least 72 hours before collection", "Disclose all androgenic compounds, anabolic steroids, and hormonal supplements", "Attend a mandatory pre-test genetic counseling session"] Indications ["Delayed or absent puberty", "Low serum LH and testosterone levels with normal pituitary imaging", "Idiopathic infertility", "Family members of a confirmed LHB mutation carrier seeking cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 21656-9 ICD-10: E23.0 Clinical summary This test identifies pathogenic variants in the LHB gene associated with hypogonadotropic hypogonadism.
TEST-5755 LIPA Gene Sequencing for Wolman Disease (NGS) Test This diagnostic test evaluates the LIPA gene for pathogenic variants associated with lysosomal acid lipase deficiency (Wolman disease and CESD).	Peripheral Whole Blood (EDTA)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LIPA gene", "Copy Number Variations (CNV) in the LIPA gene"] Parameters [] Preparation ["Patients should discuss implications with a genetic counsellor prior to sampling.", "Informed consent must be obtained."] Indications ["Suspected Wolman disease", "Suspected Cholesteryl Ester Storage Disease (CESD)", "Family history of LIPA gene mutations"] Measurement technique Confirm with laboratory Codes LOINC: 75430-1 ICD-10: E75.5 Clinical summary This diagnostic test evaluates the LIPA gene for pathogenic variants associated with lysosomal acid lipase deficiency (Wolman disease and CESD).
TEST-2619 LMNA Gene Mandibuloacral Dysplasia Genetic Test This genetic test detects pathogenic variants in the LMNA gene associated with mandibuloacral dysplasia.	Peripheral whole blood or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LMNA gene"] Parameters [] Preparation [] Indications ["Suspected mandibuloacral dysplasia", "Characteristic skeletal dysplasia and lipodystrophy"] Measurement technique Confirm with laboratory Codes LOINC: 88758-8 ICD-10: E88.81 Clinical summary This genetic test detects pathogenic variants in the LMNA gene associated with mandibuloacral dysplasia.
TEST-2193 LTBP2 Gene Weill-Marchesani Syndrome Type 3 Genetic Test This genetic test evaluates the LTBP2 gene for mutations associated with Weill-Marchesani syndrome type 3.	Peripheral whole blood or FTA card blood spot	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LTBP2 gene mutations", "Disease-causing variants"] Parameters [] Preparation ["No special preparation such as fasting is required.", "Inform the phlebotomist of any bleeding disorders or anticoagulant medications."] Indications ["Suspected Weill-Marchesani syndrome type 3", "Family history of Weill-Marchesani syndrome type 3", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.1 Clinical summary This genetic test evaluates the LTBP2 gene for mutations associated with Weill-Marchesani syndrome type 3.
TEST-3398 MAMLD1 Gene Hypospadias Type 2, X‑linked Genetic Test This test evaluates the MAMLD1 gene for mutations associated with X-linked Hypospadias Type 2.	Peripheral Whole Blood (3–5 mL in EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MAMLD1 gene mutations", "Coding exons", "Splice sites", "Deep intronic regions"] Parameters [] Preparation ["No special preparation required", "Bring valid Emirates ID", "Inform phlebotomist of current medications or infections"] Indications ["Diagnosis of X-linked Hypospadias Type 2", "Family risk assessment", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 94041-1 ICD-10: Q54.8 Clinical summary This test evaluates the MAMLD1 gene for mutations associated with X-linked Hypospadias Type 2.
TEST-5706 MARS2 Gene Spastic Ataxia Type 3 (Autosomal Recessive) Genetic Test This genetic test detects pathogenic variants in the MARS2 gene associated with autosomal recessive spastic ataxia type 3.	Whole blood (EDTA) or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MARS2 gene", "Point mutations", "Small insertions/deletions", "Copy number variants"] Parameters [] Preparation [] Indications ["Individuals with progressive gait disturbance, spasticity, and a family history of ataxia", "Early-onset spastic paraparesis", "Consanguineous families"] Measurement technique Confirm with laboratory Codes LOINC: 48726-0 ICD-10: G11.8 Clinical summary This genetic test detects pathogenic variants in the MARS2 gene associated with autosomal recessive spastic ataxia type 3.
TEST-3926 MBD1 Gene Autism Genetic Test This test evaluates the MBD1 gene for pathogenic variants associated with autism spectrum disorder (ASD). It uses Next-Generation Sequencing (NGS) to detect mutations, copy number...	Whole Blood, Extracted DNA, or FTA Card (Dried Blood Spot)	3–4 Weeks (Expedited Available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MBD1 gene coding sequence", "Pathogenic variants (SNPs, CNVs, Indels)"] Parameters [] Preparation [] Indications ["Diagnosis of autism spectrum disorder", "Genetic predisposition assessment for ASD", "Family history of neurodevelopmental disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81335-9 ICD-10: F84.0 Clinical summary This test evaluates the MBD1 gene for pathogenic variants associated with autism spectrum disorder (ASD). It uses Next-Generation Sequencing (NGS) to detect mutations, copy number variations (CNVs), and insertions/deletions (Indels).

Category overview

Genetic Sequencing: overview

Achieving a definitive diagnosis for multi-system or exceptionally rare disorders requires reading the deepest layers of your foundational biological code. As the pinnacle of our advanced Genetics department, Genetic Sequencing (including Whole Exome or Whole Genome testing) provides an incredibly detailed, high-resolution scan of your DNA. By leveraging state-of-the-art Next-Generation Sequencing technology, this expansive molecular screening helps uncover elusive genetic variants that standard tests miss, safely guiding your healthcare provider in tailoring highly personalized medical treatments and opening doors to advanced precision medicine. Consistently trusted for advanced genomic analysis across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and highly efficient reporting. Secure the definitive insights your health requires—book your genetic sequencing testing in UAE, arrange a secure clinical sample collection, or consult our dedicated medical genetics experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.